Mindways QCT Pro™ low-dose CT bone densitometry systems enables emerging markets to benefit from the latest BMD screening technology without dedicated specialist equipment operators or interruptions in screening services caused by maintenance and repair delays. QCT PRO™ software produces bone densitometry reports for both spine and hip from a low-dose abdominal CT scan with radiation doses comparable to a mammogram.

CreoMedic has over 15 years’ experience in medical imaging services, and their reputation for successful implementation and support of radiology equipment spans the Middle East, Turkey and Pakistan. With a focus on medical excellence, CreoMedic has been the main representative of QCT products throughout the Middle East and emerging markets since 2008.

Mindways VP of Business Development, Alan Brett said: “We are very pleased to partner with CreoMedic to provide the support we need to effectively execute sales, marketing, implementation and training in a region that is becoming increasingly important to us. As knowledgeable experts, CreoMedic is already adding substantial value to our operations by providing on-site local language training to radiologists and technical CT staff.”

CreoMedic Managing Director, Tony Hneiné said, “As the only system recognized as a medical device and reimbursed in countries like Turkey, we’re proud to bring Mindways Software to a market that will benefit tremendously from costs savings, automated analysis and efficient reporting in the important field of assessing osteoporosis.”

Cases of osteoporosis are increasing in the Middle East and the financial burden on healthcare systems is rapidly escalating. Adopting Mindways CT’s QCT software has the benefit of low capital investment while reducing on-going investment in site, personnel and maintenance costs by allowing hospitals and medical practices to make use of their existing CT infrastructure.

QCT bone densitometry services produce DXA-equivalent hip reports for less than the cost of buying and operating a DXA machine. Additionally, spine measurements are made in the trabecular bone volume only where the exceptional sensitivity to BMD change allows for the earliest possible diagnosis of osteoporotic conditions. Because QCT scans take less than five minutes of CT scanner time, healthcare organizations can address the growing volumes of patient traffic through improved equipment utilization without overburdening them. BMD measurements made using QCT are also used extensively in pharmaceutical clinical trials.
For more information on Mindways Software and QCT PRO™, please visit www.qct.com.

About CreoMedic SARL
CreoMedic imports, distributes and provides support and maintenance services for QCT Bone Mineral Densitometry Systems; CT Quality Control Phantoms and Teleradiology Solutions to OEMs, Hospitals and clinics across the Middle East, Turkey and Pakistan. With local language support and more than 15 years’ experience in radiology, CreoMedic staff has been delivering fully installed and implemented systems with excellent on-site training for radiologists and technologists throughout the region since 2008. For more information visit: www.creomedic.com.

About Mindways Software, Inc.
Mindways produces low-dose CT bone densitometry products for spine and hip bone density measurements. Mindways premier product, QCT PRO™ uses Quantitative CT (QCT) images to derive DXA-like hip BMD measurements and volumetric spine BMD measurements. QCT PRO™ hip BMD measurements are interpreted in the same manner as DXA, while spine measurements provide exceptional sensitivity to short-term bone density change. QCT PRO™ is fast, easy to use, reimbursable, and provides the same clinical utility as DXA at a fraction of its cost. For more information visit: www.qct.com.

Media Contact:
Alan Brett, VP Business Development
+1 512 912 0871
alan@qct.com